Search

A recent study conducted by the Polish Academy of Sciences has proposed a new method for quantitatively determining the concentration of the drug Metopimazine (MPZ) using spectrophotometry. MPZ is a dopamine antagonist used to treat nausea and vomiting, including those associated with cancer chemotherapy. The method involves measuring the absorbance of the drug's sulfoxide derivative and is specific for intact MPZ in the presence of decomposition products and excipients. The research demonstrated the possibility of quantitatively determining MPZ content in bulk drugs and tablets with a low relative standard deviation. [Extracted from the article]

A study conducted by researchers at Guangxi University in Nanning, China, explores the challenges of chemotherapy optimization due to toxic side effects, drug resistance, and individual variations in cancers. The researchers propose a new algorithm called TA-MOSSA, which takes into account these factors to provide effective chemotherapy regimens for patients with different treatment approaches. The study emphasizes the importance of precise dosing to improve efficacy and reduce toxicity. The findings of this research can be found in the journal Applied Sciences. [Extracted from the article]

A recent study conducted by researchers at Tehran University of Medical Sciences explores the topic of chemotherapy-induced alopecia (CIA), a side effect that affects more than half of chemotherapy patients. The study highlights the significant psychosocial stress associated with CIA, including body image, self-esteem, and sexuality concerns. The researchers review various techniques used to prevent CIA, such as scalp compression, scalp cooling, and medical treatments. This article provides a concise overview of the study's findings and may be of interest to individuals researching alopecia and chemotherapy side effects. [Extracted from the article]

A recent study conducted by researchers at Northwestern University explores the evolution of therapy for locally advanced rectal cancer (LARC). The standard treatment for LARC involves preoperative chemoradiotherapy followed by surgery and adjuvant systemic chemotherapy. The study aims to determine the best sequence of treatments to improve survival, cure rate, and long-term toxicity profile. The research has been peer-reviewed and published in the Journal of Surgical Oncology. For more information, readers can contact Nicole J. Altomare at Northwestern University. [Extracted from the article]

Researchers at the University of Baghdad have conducted a study on the impact of psychological scare and chemotherapy on the interaction between cancer and the immune system. The study proposes a mathematical model to explore how fear and chemotherapy affect the speed at which cancer cells multiply and the immune system's response. The researchers found that fear could contribute to the spread of tumors and weaken immune functionality. Numerical simulations were used to validate the study and determine the minimum therapy dosage needed to eradicate cancer in the presence of psychological distress. [Extracted from the article]

A recent study conducted by researchers at Henan University of Science and Technology in China explores the use of a novel tumor spheroid on a chip platform for drug screening in the treatment of esophageal cancer. The researchers developed inverse opal hydrogel scaffolds with tunable and organized pores, which allowed for the formation of uniform cell spheroids. These spheroids exhibited 3D growth patterns similar to those observed in vivo and showed increased sensitivity to chemotherapy agents compared to monolayer cells. The study suggests that this platform has potential for high-throughput tumor cell spheroid generation and drug screening, offering promise for chemotherapy drug development. [Extracted from the article]

A report from the Medical University of Silesia in Katowice, Poland discusses the challenges in treating pancreatic cancer. The five-year survival rates for this type of cancer are low, and the tumor's oligosymptomatic course and anatomical location make diagnosis difficult. Surgery and adjuvant chemotherapy are the main treatments for resectable cancer, while chemotherapy is the primary method for unresectable and metastatic cancers. The report suggests that radiotherapy, when combined with chemotherapy, could be a valuable method to improve treatment outcomes for pancreatic cancer. [Extracted from the article]

A recent study conducted by researchers at the University of Minnesota Twin Cities explores the use of chemotherapy as a treatment for cancer. The study proposes a new approach to controlling the growth of cancerous tumors by using artificial time-delayed theory. Unlike traditional methods, this approach does not rely on high-frequency switching or high gain, ensuring robustness without the need for extensive prior knowledge. Extensive simulation results support the efficacy of this proposed approach. For more information, the full article can be accessed through IEEE Access. [Extracted from the article]

Researchers from Xi'an Jiaotong-Liverpool University and other institutes in China have developed a molecule called dp53m, which targets a specific mutant version of the tumour protein P53 (TP53) called p53-R175H. This mutation is associated with lung, colorectal, and breast cancers, and can make tumours resistant to chemotherapy. The molecule, a proteolysis-targeting chimera (PROTAC), binds to the mutant protein and recruits an enzyme to break it down. Laboratory tests showed that dp53m inhibited the growth of cancer cells with the p53-R175H mutation, increased their sensitivity to chemotherapy, and did not harm healthy cells. This research suggests a potential therapeutic strategy for diseases associated with the p53-R175H mutation. [Extracted from the article]

A study conducted by researchers from Tarbiat Modares University in Tehran, Iran, explores the effect of optimal chemotherapy doses on solid tumors during treatment and cancer recurrence after treatment. The researchers designed an optimal control problem and constructed three new optimal control problems by changing the control range, objective function, and adding a control. The study found that reducing the total dose of cytotoxic drugs during treatment leads to a rapid recurrence of cancer shortly after the end of treatment. The research has been peer-reviewed and published in Mathematical Methods in the Applied Sciences. [Extracted from the article]

A new study from Guang'anmen Hospital in Beijing, China, explores the topic of arrhythmia, a common side effect of chemotherapy drugs. The study highlights the importance of addressing chemotherapy-related cardiotoxicity, which has become a leading cause of death after tumor recurrence. Traditional Chinese medicine is suggested as a potential intervention to reduce arrhythmic toxicity without compromising the anti-cancer effect of chemotherapy. The study provides an overview of the types and pathogenesis of chemotherapy-induced arrhythmia and summarizes the potential benefits of Chinese medicine compounds, combination formulas, and injections in the prevention and treatment of chemotherapy-induced arrhythmias. [Extracted from the article]

A study conducted at Taras Shevchenko National University of Kyiv in Ukraine has explored the potential of photocontrolled, biologically active compounds as drug candidates for cancer treatment. These compounds can be activated by non-ionizable light, providing a safer alternative to systemic chemotherapy. The study evaluated the potency and efficiency of these compounds in vitro and ex vivo, as well as their efficacy in vivo during early stages of drug development. The research utilized various cell cultures, tissue surrogates, and animal models to determine the most effective compounds and optimal light dosage. This study offers promising insights into the development of photopharmacology for cancer treatment. [Extracted from the article]

A recent study conducted by researchers at Liaoning University in China explores the potential benefits of combining natural anti-tumor components from Chinese herbal medicine with chemotherapy drugs in cancer treatment. The researchers highlight the diverse anti-tumor effects of these natural ingredients and their potential to reduce the adverse effects of chemotherapy drugs while inhibiting tumor growth and drug resistance. The study provides a comprehensive overview of the current research on this integrative approach and suggests that it presents a novel cancer treatment methodology. This research offers new insights for future oncological research. [Extracted from the article]